JHG

Read more
Dick Weil's photo - CEO of JHG

CEO

Dick Weil

CEO Approval Rating

63/100

Founded:

1934

Status:

PublicIndependent CompanyNYSEJHG

JHG TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

JHG's company profile
Dick Weil's photo - CEO of JHG

Dick Weil

CEO

63/100
2,053
$0
$2.6B
View Profile
1
JHG's Competitor - AllianceBernstein logo
Seth P. Bernstein's photo - President & CEO of AllianceBernstein

Seth P. Bernstein

President & CEO

67/100
3,641
$5.1B
$4.1B
View Profile
2
JHG's Competitor - BrightSphere logo
Suren Rana's photo - President & CEO of BrightSphere

Suren Rana

President & CEO

90/100
164
$325.3M
$718.5M
View Profile
3
JHG's Competitor - Eaton Vance logo
Thomas E. Faust's photo - Chairman & CEO of Eaton Vance

Thomas E. Faust

Chairman & CEO

79/100
1,680
$16.9B
$1.7B
View Profile
4
JHG's Competitor - PIMCO logo
Emmanuel Roman's photo - CEO of PIMCO

Emmanuel Roman

CEO

62/100
3,000
$13.7B
$625M
View Profile
5
JHG's Competitor - Vanguard logo
Mortimer J. Buckley's photo - Chairman & CEO of Vanguard

Mortimer J. Buckley

Chairman & CEO

74/100
17,300
- -
$2B
View Profile
6
JHG's Competitor - Franklin Templeton logo
Jennifer M. Johnson's photo - President & CEO of Franklin Templeton

Jennifer M. Johnson

President & CEO

63/100
9,600
$9B
$7.9B
View Profile
7
JHG's Competitor - Fidelity Investments logo
Abigail P. Johnson's photo - Chairman & CEO of Fidelity Investments

Abigail P. Johnson

Chairman & CEO

70/100
38,500
$3.4B
$21B
View Profile
8
JHG's Competitor - BlackRock logo
Laurence D Fink's photo - Chairman & CEO of BlackRock

Laurence D Fink

Chairman & CEO

71/100
14,900
$22.4B
$18.1B
View Profile
9
JHG's Competitor - T. Rowe Price logo
William J. Stromberg's photo - President & CEO of T. Rowe Price

William J. Stromberg

President & CEO

74/100
7,022
$205.9M
$7.1B
View Profile
10
JHG's Competitor - Schwab logo
Walter W. Bettinger II's photo - President & CEO of Schwab

Walter W. Bettinger II

President & CEO

61/100
19,500
$2.3B
$16B
View Profile
11
JHG's Competitor - Wellington Management logo
Jean Hynes's photo - CEO of Wellington Management

Jean Hynes

CEO

82/100
800
$2.3B
$1B
View Profile
12
JHG's Competitor - Putnam Investments logo
Robert L. Reynolds's photo - President & CEO of Putnam Investments

Robert L. Reynolds

President & CEO

63/100
1,500
- -
$400M
View Profile

Missing a competitor? Contribute!

AllianceBernstein is a top competitor of JHG. AllianceBernstein was founded in New York, New York} in 2000. AllianceBernstein competes in the Investment Banking & Brokerage industry. Compared to JHG, AllianceBernstein generates $1.4B more revenue.

BrightSphere is JHG's #2 competitor. BrightSphere is headquartered in Boston, Massachusetts, and was founded in 1980. BrightSphere competes in the Asset & Investment Management field. BrightSphere generates 27% the revenue of JHG.

Eaton Vance has been one of JHG's top competitors. Eaton Vance is a Private company that was founded in 1924 in Boston, Massachusetts. Eaton Vance operates in the Investment Banking & Brokerage industry. Compared to JHG, Eaton Vance has 373 fewer employees.

JHG Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$2.6B

JHG's revenue is the ranked lowest among it's top 10 competitors. The top 10 competitors average 5.9B. Over the last four quarters, JHG's revenue has grown by 29.9%. Specifically, in Q2 2021's revenue was $738.4M; in Q1 2021, it was $644M; in Q4 2020, it was $657.2M; in Q3 2020, JHG's revenue was $568.5M.

JHG Acquisitions

No recent acquisitions found related to JHG

JHG Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Sep 2020
--

Since JHG was founded in 1934, it has participated in 1 round of funding. In total JHG has raised $0. JHG's funding round was on Sep 2020 for a total of $0

JHG Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

LEXEO Therapeutics is a New York-based biotechnology company that develops and commercializes AAV-mediated treatments for genetic diseases.
$100M
Sep 08, 2021
-
Attralus is a California-based biopharmaceutical company that develops novel pan-amyloid removal therapeutics for the treatment of systemic amyloid diseases.
$116M
Sep 07, 2021
-
Disc Medicine is a Massachusetts-based biotechnology company that develops and commercializes novel therapies for the treatment of hematologic diseases.
$90M
Sep 01, 2021
-
Asher Bio is a California-based biotechnology company that develops and commercializes immunotherapies for the treatment of cancer.
$108M
Aug 31, 2021
-
DiCE Molecules is a California-based biopharmaceutical company that discovers and develops small molecular therapeutics for the treatment of autoimmune diseases.
$60M
Aug 23, 2021
-

These are all the companies that JHG has invested in. JHG has invested 70 companies and its latest investment was LEXEO Therapeutics in Sep 08,. LEXEO Therapeutics is a New York-based biotechnology company that develops and commercializes AAV-mediated treatments for genetic diseases.

JHG News

September 10, 2021DailyAlts

Janus Henderson Launches Five Sustainable ETFs

Janus Henderson Group (NYSE: JHG) announced Thursday its launch of Sustainable ETF Solutions comprisi... See more »
September 9, 2021FinSMEs

Attralus Closes $116M in Series B Financing

Attralus, Inc., a South San Francisco,...... See more »
September 9, 2021MarketScreener

Launches Five Actively Managed Sustainable Exchange Traded Funds

(marketscreener.com) Janus Henderson Group plc today announced the launch of five actively managed su... See more »
September 2, 2021FinSMEs

Disc Medicine Raises $90M in Series B Funding

Disc Medicine, a Cambridge MA-based biotechnology...... See more »
August 31, 2021Global Legal Chronicle

DiCE Molecules' $60 Million Series C-1 Financing

Wilson Sonsini Goodrich & Rosati and Fenwick & West advised DiCE Molecules on the deal. DiCE Molecule... See more »
August 26, 2021FE Investegate

Form 8.3 - Sanne Group plc

2:48 PM: Form 8.3 - Sanne Group plc... See more »

JHG Press Releases

May 6, 2021Business Wire

TwinStrand Biosciences Announces $50 Million Series B to Expand the Adoption of its Duplex Sequencing Technology in Applications Requiring the Highest Sensitivity and Accuracy

SEATTLE--(BUSINESS WIRE)-- #CLIA--TwinStrand's technology platform is delivering a new level of sensi... See more »
March 15, 2021Business Wire

Graphite Bio Secures $150 Million Series B Financing to Advance Pipeline of Next-Generation Gene Editing Therapies

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #GraphiteBio--Graphite Bio, a next-generation gene edi... See more »
December 21, 2020PR Newswire

Apartment List Announces Series D, More Than Doubles Valuation As A Profitable Company

SAN FRANCISCO, Dec. 21, 2020 /PRNewswire/ -- Apartment List, the marketplace on a mission to deliver ... See more »
December 1, 2020PR Newswire

Sight Sciences Announces Substantial Crossover Raise

MENLO PARK, Calif., Dec. 1, 2020 /PRNewswire/ -- Sight Sciences, Inc., a growth-stage medical device ... See more »
November 19, 2020centralcharts

Janus Henderson Flagship Fixed Income Offering Now Available to Hong Kong Retail Investors

Janus Henderson Flagship Fixed Income Offering Now Available to Hong Kong Retail Investors PR Newswir... See more »
November 9, 2020Business Wire

Decibel Therapeutics Announces $82M Series D Financing to Advance Gene Therapies to Restore Hearing and Balance

BOSTON--(BUSINESS WIRE)--Decibel Therapeutics, a clinical-stage biotechnology company developing nove... See more »

JHG Videos

Social Media

JHG Headquarters

201 Bishopsgate

London, EnglandEC2M 3AE

44-20-7818-1818

Driving Directions »

Trending Companies

JHG Summary

ABOUT

Overview

JHG is an asset management firm that offers funds and investment advisory services to individuals, intermediary advisors and institutional investors. JHG was founded in 1934. JHG's headquarters is located in London, England, GB EC2M 3AE. It has raised...

CEO

JHG's CEO, Dick Weil, currently has an approval rating of 63%. JHG's primary competitors are AllianceBernstein, BrightSphere & Eaton Vance.

Frequently Asked Questions about JHG

  1. When was JHG founded?

    JHG was founded in 1934
  2. Who is JHG's CEO?

    JHG's CEO is Dick Weil
  3. How much revenue does JHG generate?

    JHG generates $2.6B in revenue
  4. How much funding does JHG have?

    JHG has historically raised $0 in funding
  5. Where is JHG's headquarters?

    JHG's headquarters is in London England, GB
  1. How many employees does JHG have?

    JHG has 2,053 employees
  2. What sector does JHG operate in?

    JHG is in Asset & Investment Management
  3. Who are JHG's competitors?

    JHG's top competitors are AllianceBernstein, BrightSphere, Eaton Vance
  4. Who has JHG invested in?

    JHG's has invested in companies such as LEXEO Therapeutics, Attralus, Disc Medicine